ACTO has been recognized as a Luminary by Everest Group in their “Innovation Watch: Agentic AI in Life Sciences Commercial 2026” report. The designation acknowledges ACTO’s contributions to the development and application of agentic artificial intelligence technologies within the life sciences commercial sector. The recognition positions ACTO among leading innovators shaping the future of AI implementation in pharmaceutical and life sciences industries.
Search
